Dalla prevenzione alla riabilitazione cardiovascolare: Statine e medicina basata sulle evidenze

Translated title of the contribution: From cardiovascular prevention to cardiovascular rehabilitation: Statins and evidence-based medicine

Gian Franco Gensini, Andrea A. Conti, Antonio Conti, Antonio Panti

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The recent "Lipobay affair" prompted us to review the biomedical literature focusing on statins, in a prevention and rehabilitation perspective, and to prepare a pertinent evidence-based report. A number of randomized controlled clinical trials have assessed the efficacy and the safety of statins in cardiovascular prevention; these drugs have proved to be effective (number needed to treat values between 20 and 40) and safe (number needed to harm value for myopathy even when in association with fibrates around 833, as deduced from literature data). Fatal rhabdomyolysis is virtually not detectable in current scientific literature when statin therapy is administered in an appropriate fashion and when the patient undergoes periodical check-ups. In the individual patient, the benefits and risks related to his treatment have to be precisely tailored, evaluating his individual risk profile, the strength of the indication to statin therapy, the concomitant presence of other treatments and/or habits and the potential and actual adverse events foreseeable (to an extent) if established risk factors which predispose to myopathy are taken into consideration. The hematological lipids management strategy including a correct diet, physical exercise and statin therapy represents a key component of every evidence-based rehabilitation program too. Cardiovascular prevention and rehabilitation are major priorities at an individual as well as at a public health level. Both these strategies are based on a careful management of known risk factors, among them hypercholesterolemia, that today can be effectively and safely treated with statins.

Original languageItalian
Pages (from-to)91-94
Number of pages4
JournalItalian Heart Journal Supplement
Volume3
Issue number1
Publication statusPublished - 2002

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Evidence-Based Medicine
Muscular Diseases
Rehabilitation
Literature
Fibric Acids
Exercise Therapy
Numbers Needed To Treat
Rhabdomyolysis
Therapeutics
Hypercholesterolemia
Habits
Cardiac Rehabilitation
Randomized Controlled Trials
Public Health
Exercise
Diet
Lipids
Safety
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Dalla prevenzione alla riabilitazione cardiovascolare : Statine e medicina basata sulle evidenze. / Gensini, Gian Franco; Conti, Andrea A.; Conti, Antonio; Panti, Antonio.

In: Italian Heart Journal Supplement, Vol. 3, No. 1, 2002, p. 91-94.

Research output: Contribution to journalArticle

Gensini, Gian Franco ; Conti, Andrea A. ; Conti, Antonio ; Panti, Antonio. / Dalla prevenzione alla riabilitazione cardiovascolare : Statine e medicina basata sulle evidenze. In: Italian Heart Journal Supplement. 2002 ; Vol. 3, No. 1. pp. 91-94.
@article{b8b401206cfa4f4d8b871db2a2d27f35,
title = "Dalla prevenzione alla riabilitazione cardiovascolare: Statine e medicina basata sulle evidenze",
abstract = "The recent {"}Lipobay affair{"} prompted us to review the biomedical literature focusing on statins, in a prevention and rehabilitation perspective, and to prepare a pertinent evidence-based report. A number of randomized controlled clinical trials have assessed the efficacy and the safety of statins in cardiovascular prevention; these drugs have proved to be effective (number needed to treat values between 20 and 40) and safe (number needed to harm value for myopathy even when in association with fibrates around 833, as deduced from literature data). Fatal rhabdomyolysis is virtually not detectable in current scientific literature when statin therapy is administered in an appropriate fashion and when the patient undergoes periodical check-ups. In the individual patient, the benefits and risks related to his treatment have to be precisely tailored, evaluating his individual risk profile, the strength of the indication to statin therapy, the concomitant presence of other treatments and/or habits and the potential and actual adverse events foreseeable (to an extent) if established risk factors which predispose to myopathy are taken into consideration. The hematological lipids management strategy including a correct diet, physical exercise and statin therapy represents a key component of every evidence-based rehabilitation program too. Cardiovascular prevention and rehabilitation are major priorities at an individual as well as at a public health level. Both these strategies are based on a careful management of known risk factors, among them hypercholesterolemia, that today can be effectively and safely treated with statins.",
keywords = "Evidence-based medicine, Ischemic heart disease, Prevention, Rehabilitation, Statins",
author = "Gensini, {Gian Franco} and Conti, {Andrea A.} and Antonio Conti and Antonio Panti",
year = "2002",
language = "Italian",
volume = "3",
pages = "91--94",
journal = "Italian Heart Journal Supplement",
issn = "1129-4728",
publisher = "Centro Editoriale Pubblicitario Italiano",
number = "1",

}

TY - JOUR

T1 - Dalla prevenzione alla riabilitazione cardiovascolare

T2 - Statine e medicina basata sulle evidenze

AU - Gensini, Gian Franco

AU - Conti, Andrea A.

AU - Conti, Antonio

AU - Panti, Antonio

PY - 2002

Y1 - 2002

N2 - The recent "Lipobay affair" prompted us to review the biomedical literature focusing on statins, in a prevention and rehabilitation perspective, and to prepare a pertinent evidence-based report. A number of randomized controlled clinical trials have assessed the efficacy and the safety of statins in cardiovascular prevention; these drugs have proved to be effective (number needed to treat values between 20 and 40) and safe (number needed to harm value for myopathy even when in association with fibrates around 833, as deduced from literature data). Fatal rhabdomyolysis is virtually not detectable in current scientific literature when statin therapy is administered in an appropriate fashion and when the patient undergoes periodical check-ups. In the individual patient, the benefits and risks related to his treatment have to be precisely tailored, evaluating his individual risk profile, the strength of the indication to statin therapy, the concomitant presence of other treatments and/or habits and the potential and actual adverse events foreseeable (to an extent) if established risk factors which predispose to myopathy are taken into consideration. The hematological lipids management strategy including a correct diet, physical exercise and statin therapy represents a key component of every evidence-based rehabilitation program too. Cardiovascular prevention and rehabilitation are major priorities at an individual as well as at a public health level. Both these strategies are based on a careful management of known risk factors, among them hypercholesterolemia, that today can be effectively and safely treated with statins.

AB - The recent "Lipobay affair" prompted us to review the biomedical literature focusing on statins, in a prevention and rehabilitation perspective, and to prepare a pertinent evidence-based report. A number of randomized controlled clinical trials have assessed the efficacy and the safety of statins in cardiovascular prevention; these drugs have proved to be effective (number needed to treat values between 20 and 40) and safe (number needed to harm value for myopathy even when in association with fibrates around 833, as deduced from literature data). Fatal rhabdomyolysis is virtually not detectable in current scientific literature when statin therapy is administered in an appropriate fashion and when the patient undergoes periodical check-ups. In the individual patient, the benefits and risks related to his treatment have to be precisely tailored, evaluating his individual risk profile, the strength of the indication to statin therapy, the concomitant presence of other treatments and/or habits and the potential and actual adverse events foreseeable (to an extent) if established risk factors which predispose to myopathy are taken into consideration. The hematological lipids management strategy including a correct diet, physical exercise and statin therapy represents a key component of every evidence-based rehabilitation program too. Cardiovascular prevention and rehabilitation are major priorities at an individual as well as at a public health level. Both these strategies are based on a careful management of known risk factors, among them hypercholesterolemia, that today can be effectively and safely treated with statins.

KW - Evidence-based medicine

KW - Ischemic heart disease

KW - Prevention

KW - Rehabilitation

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=0036204824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036204824&partnerID=8YFLogxK

M3 - Articolo

C2 - 11899580

AN - SCOPUS:0036204824

VL - 3

SP - 91

EP - 94

JO - Italian Heart Journal Supplement

JF - Italian Heart Journal Supplement

SN - 1129-4728

IS - 1

ER -